In vivo distribution of chromium from chromium picolinate in rats and implications for the safety of the dietary supplement

Chemical Research in Toxicology

Volumn 15, Issue 2, 2002, Pages 93-100

  Hepburn, Dion D D ^a   Vincent, John B ^a  

^a UNIVERSITY OF ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; CHROMIUM PICOLINATE;

ABSORPTION; ACIDITY; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA DAMAGE; IN VITRO STUDY; LIVER CELL; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; RAT;

ANIMALS; CELL FRACTIONATION; CHROMIUM RADIOISOTOPES; DIETARY SUPPLEMENTS; HEPATOCYTES; INJECTIONS, INTRAVENOUS; IRON CHELATING AGENTS; MALE; PICOLINIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; TRITIUM;

ANIMALIA;

EID: 0036170890     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx010091t     Document Type: Article

References (54)

1. Chromium picolinate market sees robust growth and high demand
2. Dietary chromium effects on tissue chromium concentrations and chromium absorption in rats
3. 51Cr picolinate in a rat model
4. Is chromium supplementation effective in managing type II diabetes?
5. Chromium as a supplement
6. The bioinorganic chemistry of chromium(III)
7. Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells
8. Comparative induction of oxidative stress in cultured J774A.1 macrophage cells by chromium picolinate and chromium nicotinate
9. A prediction of chromium(III) accumulation in humans from chromium dietary supplements
10. The nutritional supplement chromium(III) tris(picolinate) cleaves DNA
11. The binding of trivalent chromium to low-molecular-weight chromium-binding substance (LMWCr) and the transfer of chromium from transferrin and chromium picolinate to LMWCr
12. Oxygen radical-mediated DNA damage by redox-active Cr(III) complexes
13. Chromium picolinate toxicity
14. Chronic renal failure after ingestion of over-the-counter chromium picolinate
15. To the editor
16. To the editor
17. To the editor
18. To the editor
19. In response
20. Suspected chromium picolinate-induced rhabdomyolysis
21. Systemic contact dermatitis caused by oral chromium picolinate
22. Over-the-counter chromium picolinate
23. Acute generalized exanthematous postulosis induced by chromium picolinate
24. Effect of supplementation with chromium picolinate on antibody titers to 5-hydroxymethyl uracil
25. Rat chromosomes are unharmed by orally administered chromium picolinate
26. 2O (Hpic = picolinic acid)
27. In vitro metabolism and permeation studies in rat jejunum: Organic chromium compared to inorganic chromium
28. Release of Cr(III) from chromium(III)-picolinate upon metabolic activation
29. The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects
30. Nuclear magnetic resonance studies of chromium(III) pyridinecarboxylate complexes
31. The trail of chromium(III) in vivo from the blood to the urine: The roles of transferrin and chromodulin
32. Lack of toxicity of chromium chloride and chromium picolinate in rats
33. Biological activity and fate of trace quantities of intravenous chromium(III) in rats
34. Compartment analysis of metabolism of chromium(III) in rats of various ages
35. Kinetics of trace element chromium(III) in the human body
36. The stability of the biomimetic cation triaqua-μ-oxohexapropionatotrichromium(III) in vivo in rats
37. Studies on a specific chromium binding substance (a low-molecular-weight chromium binding substance) in urine
38. 51(III) with time
39. 51chromium in bile-duct cannulated rats
40. Biliary and gastrointestinal excretion of chromium after administration of Cr-III or Cr-VI in rats
41. Dietary chromium effects on tissue chromium concentrations and chromium absorption in rats
42. DNA interactions and bacterial mutagenicity of some chromium(III) imine complexes and their chromium(V) analogues. Evidence for chromium(V) intermediates in the genotoxicity of chromium(III)
43. Permability, cytotoxicity and genotoxicity of Cr(III) complexes and Cr(V) analogues in V79 Chinese hamster lung cells
44. + do not cleave DNA under physiologically relevant conditions
45. The role of chromium in nutrition and therapeutics and as a potential toxin
46. Safety limits for nutrients
47. Formation of picolinic acid and quinolinic acids following enzymatic oxidation of 3-hydroxyanthranilic acid
48. Zinc binding ligands and complexes in zinc metabolism
49. Physiological ligands for copper and zinc
50. Morphological changes induced by picolinic acid in cultured mammalian cells
51. The addition of picolinic acid to low protein diets - A word of caution
52. Influence of dietary picolinic acid on mineral metabolism in the rat
53. Neurotoxicity of tryptophan metabolites